Influence of genetic variants in asparaginase pathway on the susceptibility to asparaginase-related toxicity and patients' outcome in childhood acute lymphoblastic leukemia
- 7 May 2021
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 88 (2) , 313-321
Abstract
Background Asparaginase (ASNase) is a key component in the treatment protocols of childhood acute lymphoblastic leukemia (ALL). Asparagine synthetase (ASNS) and the basic region leucine zipper activating transcription factor 5 (ATF5) mediate the anti-leukemic effect of ASNase. Only a few reports studied the association between polymorphisms in these genes and treatment-related toxicity and response. Therefore, the current study aimed to investigate the association of ASNS and ATF5 polymorphisms with the susceptibility to ASNase-related toxicity and disease outcome in a population of childhood ALL Egyptian patients. Methods In this study, 88 children with ALL were enrolled and genotyped for ASNS T629A and ATF5 C362T polymorphisms using allelic discrimination assay. Results The studied polymorphisms did not associate with hypersensitivity or thrombosis, while the ATF5 C362T polymorphism was associated significantly with decreased ASNase-associated pancreatitis (AAP) risk under the dominant model. Patients carrying TT/CT genotypes of ATF5 C362T polymorphism had a significantly better overall survival (OS) and longer event-free survival (EFS) compared to patients with CC genotype. Multivariate analysis confirmed the independent prognostic value of the ATF5 C362T dominant model. Conclusion ATF5 362TT and CT genotypes were associated with decreased risk to develop AAP and better disease outcome demonstrating a low risk for events and superior survival.Keywords
This publication has 40 references indexed in Scilit:
- Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemiaFrontiers in Genetics, 2012
- ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemiaBlood, 2011
- BCL-2 Is a Downstream Target of ATF5 That Mediates the Prosurvival Function of ATF5 in a Cell Type-dependent MannerJournal of Biological Chemistry, 2011
- Missense mutations in dystrophin that trigger muscular dystrophy decrease protein stability and lead to cross-β aggregatesProceedings of the National Academy of Sciences, 2010
- Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cellsLeukemia Research, 2009
- Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase‐associated pancreatitisPediatric Blood & Cancer, 2009
- The transcription factor ATF5: role in neurodevelopment and neural tumorsJournal of Neurochemistry, 2008
- Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginaseJournal of Clinical Investigation, 2007
- Amino acid limitation induces expression of ATF5 mRNA at the post-transcriptional levelLife Sciences, 2007
- Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemiaBlood, 2006